(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.02%) 15 928 points
(-0.80%) $83.18
(1.04%) $1.943
(-0.34%) $2 339.20
(0.04%) $27.55
(0.73%) $928.80
(-0.15%) $0.933
(-0.11%) $11.01
(-0.22%) $0.799
(0.25%) $92.11
Live Chart Being Loaded With Signals
ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry...
Stats | |
---|---|
Šios dienos apimtis | 85 748.00 |
Vidutinė apimtis | 158 474 |
Rinkos kapitalizacija | 72.83M |
EPS | £0 ( 2023-11-27 ) |
Kita pelno data | ( £0 ) 2024-07-08 |
Last Dividend | £1.000 ( 2021-09-23 ) |
Next Dividend | £0 ( N/A ) |
P/E | -53.75 |
ATR14 | £0.698 (0.65%) |
ECO Animal Health Group Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
ECO Animal Health Group Finansinės ataskaitos
Annual | 2022 |
Pajamos: | £85.31M |
Bruto pelnas: | £36.75M (43.08 %) |
EPS: | £0.0149 |
FY | 2022 |
Pajamos: | £85.31M |
Bruto pelnas: | £36.75M (43.08 %) |
EPS: | £0.0149 |
FY | 2022 |
Pajamos: | £82.20M |
Bruto pelnas: | £35.14M (42.75 %) |
EPS: | £-0.0104 |
FY | 2021 |
Pajamos: | £105.61M |
Bruto pelnas: | £53.62M (50.77 %) |
EPS: | £0.121 |
Financial Reports:
No articles found.
ECO Animal Health Group Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
First Dividend | £0.500 | 1995-12-29 |
Last Dividend | £1.000 | 2021-09-23 |
Next Dividend | £0 | N/A |
Payout Date | 2021-10-22 | |
Next Payout Date | N/A | |
# dividends | 47 | -- |
Total Paid Out | £142.76 | -- |
Avg. Dividend % Per Year | 0.05% | -- |
Score | 2.41 | -- |
Div. Sustainability Score | 8.45 | |
Div.Growth Potential Score | 1.041 | |
Div. Directional Score | 4.74 | -- |
Year | Amount | Yield |
---|---|---|
1995 | £0 | 0.00% |
1996 | £0 | 0.00% |
1997 | £0 | 0.00% |
1998 | £0 | 0.00% |
1999 | £0 | 0.00% |
2000 | £0 | 0.00% |
2001 | £0 | 0.00% |
2002 | £0 | 0.00% |
2003 | £0 | 0.00% |
2004 | £0 | 0.00% |
2005 | £0 | 0.00% |
2006 | £0 | 0.00% |
2007 | £0 | 0.00% |
2008 | £0 | 0.00% |
2009 | £0 | 0.00% |
2010 | £0 | 0.00% |
2011 | £0 | 0.00% |
2012 | £0 | 0.00% |
2013 | £0 | 0.00% |
2014 | £0 | 0.00% |
2015 | £0 | 0.00% |
2016 | £0 | 0.00% |
2017 | £0 | 0.00% |
2018 | £12.70 | 2.20% |
2019 | £15.04 | 3.62% |
2020 | £0 | 0.00% |
2021 | £1.000 | 0.40% |
2022 | £0 | 0.00% |
2023 | £0 | 0.00% |
2024 | £0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SGE.L | Dividend Knight | 2023-06-01 | Semi-Annually | 32 | 1.64% | |
IEML.L | No Dividend Player | 2023-08-10 | Insufficient data to determine frequency | 2 | 1.30% | |
BME.L | Dividend King | 2023-06-29 | Semi-Annually | 11 | 4.74% | |
XPP.L | Dividend Knight | 2023-09-07 | Quarterly | 18 | 1.72% | |
NWOR.L | Dividend Knight | 2023-06-01 | Insufficient data to determine frequency | 2 | 0.88% | |
ENT.L | Dividend Junior | 2023-08-17 | Annually | 19 | 0.58% | |
SRE.L | Dividend Knight | 2023-07-13 | Semi-Annually | 18 | 2.26% | |
JGGI.L | Dividend King | 2023-08-31 | Quarterly | 53 | 2.32% | |
BYIT.L | Dividend Knight | 2023-07-20 | Annually | 4 | 0.95% | |
PRSR.L | Dividend Knight | 2023-08-10 | Quarterly | 7 | 2.62% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0184 | 1.500 | -0.367 | -0.551 | [0 - 0.5] |
returnOnAssetsTTM | -0.0141 | 1.200 | -0.469 | -0.563 | [0 - 0.3] |
returnOnEquityTTM | -0.0197 | 1.500 | -1.330 | -1.995 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 3.16 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 2.25 | 0.800 | 1.499 | 1.199 | [0.8 - 2.5] |
cashRatioTTM | 0.954 | 1.500 | 5.81 | 8.72 | [0.2 - 2] |
debtRatioTTM | 0.0359 | -1.500 | 9.40 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 5.08 | 1.000 | 9.23 | 9.23 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.278 | 2.00 | 9.91 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.199 | 2.00 | 9.90 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0508 | -1.500 | 9.80 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.430 | 1.000 | 6.16 | 6.16 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0358 | 1.000 | -1.285 | -1.285 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 4.55 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.767 | 0.800 | 8.22 | 6.58 | [0.5 - 2] |
Total Score | 8.45 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -44.83 | 1.000 | -4.63 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0197 | 2.50 | -0.855 | -1.995 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.199 | 2.00 | 9.93 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.278 | 2.00 | 9.91 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -18.11 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.213 | 1.000 | 7.17 | 0 | [0.1 - 0.5] |
Total Score | 1.041 |
ECO Animal Health Group
ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. ECO Animal Health Group plc was founded in 1972 and is headquartered in New Malden, the United Kingdom.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.